The announcement saw Beingmate shares listed on the Shenzhen Stock Exchange climb three per cent to 5.44 yuan before pulling back to 5.38 yuan yesterday.
The news comes as Fonterra reviews its poorly performing investment in the Chinese infant formula manufacturer along with other assets. Chairman John Monaghan has said the company was doing a "full stock take and portfolio review" looking at all major investments, assets and joint ventures."
Fonterra paid 18 yuan per share for a total outlay of NZ$755 million as part of a joint venture partnership. It has since written down the carrying value to $204m after a string of heavy losses decimated Beingmate's market value.
Guangzhou's Yangcheng Evening News quoted dairy analyst Song Liang saying Beingmate courting Chinese Government-backed investment opportunities could offer a solution to both partners.
"Do not rule out that Fonterra really wants to withdraw, and then the shares are transferred to the state-owned background investors."
Fonterra declined to comment.
Beingmate has shown improved financials after posting successive losses of 780m yuan ($164m) in 2016 and 1.06 billion yuan ($223m) in 2017.
The company turned in a profit of 19.43m yuan in the third quarter of 2018, and a nine month profit of 27.96m yuan, an increase of 107.3 per cent.
Since April, Beingmate shares have been market ST (Special Treatment) which carries a delisting warning, and the company has been repeatedly warned for violations of information disclosure.
China is one of Fonterra's largest global markets, accounting for $3.4 billion of sales revenue and a normalised earnings contribution of more than $200 million.
In 2015 when Fonterra announced the joint venture, former chief executive Theo Spierings said the deal was a game changer for the co-operative in China. However, it has been a financial disaster that many shareholders want to see the back of.